Laurence Roope

Dr. Laurence Roope

University of Oxford, UK
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2019 in Science
Verified
Journal Article
Closed access
PDF file
Laurence RoopeLaurence Roope
Laurence Roope
RSRichard Smith
Richard Smith
KPKoen Pouwels
Koen Pouwels
JBJames Buchanan
James Buchanan
LALucy Abel
Lucy Abel
SWSarah Wordsworth
Sarah Wordsworth
Incentivizing restraint in drug use: The accelerating tide of antimicrobial resistance (AMR) is a major worldwide policy concern. Like climate change, the incentives for individual decision-makers do not take into account the costs to society at large. AMR represents an impending “tragedy of the commons,” and there is an immediate need for collective action to prevent future harm. Roope et al. review the issues associated with AMR from an economics perspective and draw parallels with climate change. A major stumbling block for both challenges is to build consensus about the best way forward when faced with many uncertainties and inequities. Science , this issue p. eaau4679

11 April 2023 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
MVMara Violato
Mara Violato
JPJack Pollard
Jack Pollard
ALAndrew J. Lloyd
Andrew J. Lloyd
Laurence RoopeLaurence Roope
Laurence Roope
RDRaymond Duch
Raymond Duch
PCPhilip M. Clarke
Philip M. Clarke
Background: Most research on the Coronavirus Disease 2019 (COVID-19) health burden has focused on confirmed cases and deaths, rather than consequences for the general population’s health-related quality of life (HRQoL). It is also important to consider HRQoL to better understand the potential multifaceted implications of the COVID-19 pandemic in various international contexts. This study aimed to assess the association between the COVID-19 pandemic and changes in HRQoL in 13 diverse countries. Methods and findings: Adults (18+ years) were surveyed online (24 November to 17 December 2020) in 13 countries spanning 6 continents. Our cross-sectional study used descriptive and regression-based analyses (age adjusted and stratified by gender) to assess the association between the pandemic and changes in the general population’s HRQoL, measured by the EQ-5D-5L instrument and its domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), and how overall health deterioration was associated with individual-level (socioeconomic, clinical, and experiences of COVID-19) and national-level (pandemic severity, government responsiveness, and effectiveness) factors. We also produced country-level quality-adjusted life years (QALYs) associated to COVID-19 pandemic-related morbidity. We found that overall health deteriorated, on average across countries, for more than one-third of the 15,480 participants, mostly in the anxiety/depression health domain, especially for younger people (<35 years old) and females/other gender. This translated overall into a 0.066 mean “loss” (95% CI: −0.075, −0.057; p-value < 0.001) in the EQ-5D-5L index, representing a reduction of 8% in overall HRQoL. QALYs lost associated with morbidity were 5 to 11 times greater than QALYs lost based on COVID-19 premature mortality. A limitation of the study is that participants were asked to complete the prepandemic health questionnaire retrospectively, meaning responses may be subject to recall bias. Conclusions: In this study, we observed that the COVID-19 pandemic was associated with a reduction in perceived HRQoL globally, especially with respect to the anxiety/depression health domain and among younger people. The COVID-19 health burden would therefore be substantially underestimated if based only on mortality. HRQoL measures are important to fully capture morbidity from the pandemic in the general population.

15 September 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RDRaymond Duch
Raymond Duch
Laurence RoopeLaurence Roope
Laurence Roope
MVMara Violato
Mara Violato
MBMatias Fuentes Becerra
Matias Fuentes Becerra
TRThomas S. Robinson
Thomas S. Robinson
PCPhilip M. Clarke
Philip M. Clarke
Significance: How to allocate COVID-19 vaccines is one of the most important decisions currently facing governments. With limited supplies, what is most pressing is deciding who gets priority in the vaccine allocation rollout. Some governments are exploring allowing private purchases of COVID-19 vaccines. Many countries are debating whether COVID-19 vaccines should be mandated. There is little evidence on what policies are preferred by the global public. Our survey of 15,536 adults in 13 countries confirms that priority should be given to health workers and those at high risk but also, to a broad range of key workers and those with lower incomes. The public favors allocating COVID-19 vaccines solely via government programs but was polarized in some countries on mandatory vaccinations.

21 June 2018 in Eurosurveillance
Verified
Journal Article
Open access
Laurence RoopeLaurence Roope
Laurence Roope
STSarah Tonkin-Crine
Sarah Tonkin-Crine
CBChristopher Butler
Christopher Butler
DCDerrick Crook
Derrick Crook
TPTim Peto
Tim Peto
SWSarah Wordsworth
Sarah Wordsworth
Background: Antimicrobial resistance (AMR), a major public health threat, is strongly associated with human antibiotic consumption. Influenza-like illnesses (ILI) account for substantial inappropriate antibiotic use; patient understanding and expectations probably play an important role. Aim: This study aimed to investigate what drives patient expectations of antibiotics for ILI and particularly whether AMR awareness, risk preferences (attitudes to taking risks with health) or time preferences (the extent to which people prioritise good health today over good health in the future) play a role. Methods: In 2015, a representative online panel survey of 2,064 adults in the United Kingdom was asked about antibiotic use and effectiveness for ILI. Explanatory variables in multivariable regression included AMR awareness, risk and time preferences and covariates. Results: The tendency not to prioritise immediate gain over later reward was independently strongly associated with greater awareness that antibiotics are inappropriate for ILI. Independently, believing antibiotics were effective for ILI and low AMR awareness significantly predicted reported antibiotic use. However, 272 (39%) of those with low AMR awareness said that the AMR information we provided would lead them to ask a doctor for antibiotics more often, significantly more than would do so less often, and in contrast to those with high AMR awareness (p < 0.0001). Conclusion: Information campaigns to reduce AMR may risk a paradoxical consequence of actually increasing public demand for antibiotics. Public antibiotic stewardship campaigns should be tested on a small scale before wider adoption.

14 December 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
ABAleksandra J. Borek
Aleksandra J. Borek
KMKatherine Maitland
Katherine Maitland
MMMonsey McLeod
Monsey McLeod
ACanne campbell
anne campbell
BHBenedict Hayhoe
Benedict Hayhoe
OTon behalf of the STEP-UP Study Team
on behalf of the STEP-UP Study Team
The COVID-19 pandemic has had a profound impact on the delivery of primary care services. We aimed to identify general practitioners’ (GPs’) perceptions and experiences of how the COVID-19 pandemic influenced antibiotic prescribing and antimicrobial stewardship (AMS) in general practice in England. Twenty-four semi-structured interviews were conducted with 18 GPs at two time-points: autumn 2020 (14 interviews) and spring 2021 (10 interviews). Interviews were audio-recorded, transcribed and analysed thematically, taking a longitudinal approach. Participants reported a lower threshold for antibiotic prescribing (and fewer consultations) for respiratory infections and COVID-19 symptoms early in the pandemic, then returning to more usual (pre-pandemic) prescribing. They perceived the pandemic as having had less impact on antibiotic prescribing for urinary and skin infections. Participants perceived the changing ways of working and consulting (e.g., proportions of remote and in-person consultations) in addition to changing patient presentations and GP workloads as influencing the fluctuations in antibiotic prescribing. This was compounded by decreased engagement with, and priority of, AMS due to COVID-19-related urgent priorities. Re-engagement with AMS is needed, e.g., through reviving antibiotic prescribing feedback and targets/incentives. The pandemic disrupted, and required adaptations in, the usual ways of working and AMS. It is now important to identify opportunities, e.g., for re-organising ways of managing infections and AMS in the future.

30 March 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
PCPhilip M. Clarke
Philip M. Clarke
Laurence RoopeLaurence Roope
Laurence Roope
PLPeter John Loewen
Peter John Loewen
JBJean-Francois Bonnefon
Jean-Francois Bonnefon
AMAlessia Melegaro
Alessia Melegaro
RDRaymond Duch
Raymond Duch